Bill Gates (Leon Neal/Pool via AP Images)

A cen­tu­ry af­ter the last ma­jor TB vac­cine break­through, Gates and Well­come com­mit $550M for PhI­II test of GSK shot

Two non­prof­it or­ga­ni­za­tions are team­ing up for a gi­ant study of an ex­per­i­men­tal vac­cine de­signed to pro­tect against the world’s dead­liest in­fec­tious dis­ease.

The Bill …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.